US SPECIALTY FORMULATIONS RECOGNIZED AS ONE OF THE 50 FEATURED COMPANIES AT THE 2023 MID-ATLANTIC CAPITAL CONFERENCE
ALLENTOWN, PA, US, October 12, 2023 /EINPresswire.com/ -- US Specialty Formulations, LLC, (USSF), a leader in high-quality pharmaceutical presentations, is pleased to announce that QYNDR, its oral vaccine platform, has been selected as one of the 50 …